Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A52810 | 21473944 | N Biotechnol | Antibodies in metabolic diseases. | 2011 | Details |
A52816 | 21382161 | Liver Int | Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. | 2011 | Details |
A52824 | 21258310 | Med Glas (Zenica) | Increased P wave dispersion in patients with liver steatosis. | 2010 | Details |
A52825 | 21252254 | J Clin Endocrinol Metab | Preadipocyte factor-1 is associated with metabolic profile in severe obesity. | 2011 | Details |
A52828 | 21194577 | Am J Med | Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time? | 2011 | Details |
A52829 | 21205225 | Basic Clin Pharmacol Toxicol | Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice. | 2011 | Details |
A52835 | 21110886 | BMC Genomics | Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity. | 2010 | Details |
A52841 | 20980637 | J Nutr | Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs. | 2010 | Details |
A52847 | 20824098 | PLoS One | Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. | 2010 | Details |
A52856 | 20619595 | Presse Med | [Radical complications of obesity]. | 2010 | Details |
A52857 | 20592272 | Endocr Rev | Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. | 2010 | Details |
A52858 | 20578130 | Hepatology | Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors. | 2010 | Details |
A52883 | 20106640 | Nutr Metab Cardiovasc Dis | Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity. | 2010 | Details |
A52903 | 19796705 | Biochim Biophys Acta | Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. | 2009 | Details |
A52905 | 19755595 | Radiographics | Imaging-based quantification of hepatic fat: methods and clinical applications. | 2009 | Details |
A52910 | 19689382 | Infect Disord Drug Targets | Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. | 2009 | Details |
A52911 | 19686868 | Clin Gastroenterol Hepatol | Ethnicity and body mass index are associated with hepatitis C presentation and progression. | 2009 | Details |
A52917 | 19549757 | J Nutr | Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. | 2009 | Details |
A52922 | 19501581 | Clin Biochem | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. | 2009 | Details |
A52925 | 19461572 | Minerva Pediatr | Total parenteral nutrition in patients with short bowel syndrome. | 2009 | Details |
A52932 | 19358089 | Exp Clin Endocrinol Diabetes | Adipose tissue dysfunction in obesity. | 2009 | Details |
A52933 | 19357846 | Semin Immunopathol | The emerging role of the endocannabinoid system in cardiovascular disease. | 2009 | Details |
A52937 | 19277603 | Diabetologia | Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy. | 2009 | Details |
A52956 | 18853998 | J Gastroenterol Hepatol | Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. | 2008 | Details |
A52957 | 18853970 | Am J Gastroenterol | Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. | 2008 | Details |
A52963 | 18751917 | Subcell Biochem | The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. | 2008 | Details |
A52970 | 18630061 | Rev Med Suisse | [Metabolic syndrome, a mitochondrial disease?]. | 2008 | Details |
A52971 | 18619057 | Gac Med Mex | [Obesity, inflammation and diabetes]. | 2008 | Details |
A52980 | 18436717 | Clin Chem | The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. | 2008 | Details |
A52983 | 18335040 | PLoS One | Fetuin-A induces cytokine expression and suppresses adiponectin production. | 2008 | Details |
A52989 | 18220945 | Endocr Metab Immune Disord Drug Targets | Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets? | 2007 | Details |
A52990 | 18220654 | Curr Diabetes Rev | Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. | 2007 | Details |
A52996 | 18157836 | Hepatology | Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. | 2008 | Details |
A53000 | 17999758 | Theor Biol Med Model | Inflammation: a way to understanding the evolution of portal hypertension. | 2007 | Details |
A53003 | 17785696 | Eur J Endocrinol | Fat distribution and storage: how much, where, and how? | 2007 | Details |
A53004 | 19124394 | Ther Adv Cardiovasc Dis | Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. | 2007 | Details |
A53005 | 17901224 | Endocrinology | Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. | 2007 | Details |
A53017 | 17320517 | Am J Med | Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. | 2007 | Details |
A53027 | 17106922 | World J Gastroenterol | Mechanisms and significance of liver steatosis in hepatitis C virus infection. | 2006 | Details |
A53029 | 17016629 | Int J Mol Med | Hemostasis alterations in metabolic syndrome (review). | 2006 | Details |
A53034 | 16903166 | Clin Cornerstone | Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. | 2006 | Details |
A53040 | 16709420 | J Comp Pathol | Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells. | 2006 | Details |
A53042 | 16697727 | Gastroenterology | Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. | 2006 | Details |
A53048 | 16511589 | J Clin Invest | Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. | 2006 | Details |
A53049 | 16478779 | Am J Physiol Endocrinol Metab | Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. | 2006 | Details |
A53053 | 16424352 | Arterioscler Thromb Vasc Biol | Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. | 2006 | Details |
A53054 | 16409152 | Annu Rev Med | Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. | 2006 | Details |
A53069 | 15802977 | AIDS | Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. | 2005 | Details |
A53074 | 15632045 | J Nucl Med | Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation. | 2005 | Details |
A53076 | 15556248 | Clin Nutr | Acute and "chronic" phase reaction-a mother of disease. | 2004 | Details |
A53080 | 15520626 | MedGenMed | Etiology and pathogenesis of necrolytic migratory erythema: review of the literature. | 2004 | Details |
A53086 | 15230153 | Przegl Lek | [Adiponectin--adipocytokine with a broad clinical spectrum]. | 2004 | Details |
A53087 | 15181027 | J Clin Endocrinol Metab | Medical consequences of obesity. | 2004 | Details |
A53096 | 15010338 | Am J Physiol Endocrinol Metab | Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. | 2004 | Details |
A53098 | 14739074 | Biochimie | Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones. | 2003 | Details |
A53109 | 12901271 | Wiad Lek | [Alcoholic liver disease]. | 2003 | Details |
A53110 | 12793594 | Int J Clin Pract Suppl | The relationship of obesity to the metabolic syndrome. | 2003 | Details |
A53112 | 12733392 | Presse Med | [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]. | 2003 | Details |
A53113 | 12702985 | J Clin Gastroenterol | Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. | 2003 | Details |
A53116 | 12585002 | Srp Arh Celok Lek | [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease]. | 2003 | Details |
A53128 | 11729749 | Adv Anat Embryol Cell Biol | Cooperation of liver cells in health and disease. | 2001 | Details |
A53136 | 10905124 | Ital Heart J | [Ischemic cardiopathy: risk factors and their biological role]. | 2000 | Details |
A53151 | 9763522 | Arterioscler Thromb Vasc Biol | Sphingolipids in atherosclerosis and vascular biology. | 1998 | Details |
A53155 | 9670624 | Indian J Pathol Microbiol | Observations on hepatic structure and function in fibro-calculous pancreatic diabetes (FCPD) vis-a-vis other diabetic subtypes. | 1998 | Details |
A53174 | 1912448 | J Gastroenterol Hepatol | Pathological and laboratory findings in LEC/Otk rats that spontaneously develop hepatic injury. | 1991 | Details |
A53186 | 6251498 | Prostaglandins Med | Decrease of eicosapentaenoic acid in fatty liver of diabetic subjects. | 1980 | Details |